|
Market Closed -
NYSE
01:30:02 29/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 245.62 USD | +1.26% |
|
+2.80% | +41.54% |
| 28/10 | Evercore ISI Adjusts Price Target on Quest Diagnostics to $240 From $235 | MT |
| 27/10 | Rothschild & Co Redburn Adjusts Price Target on Quest Diagnostics to $279 From $251 | MT |
| Market Cap | 2.7TCr 2.42TCr 2.24TCr 2.03TCr 3.79TCr 2,57400Cr 3.84TCr 27TCr 11TCr 1,34700Cr 10TCr 9.93TCr 4,27500Cr | P/E 2026 * |
23.8x | P/E 2027 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3.2TCr 2.87TCr 2.66TCr 2.4TCr 4.49TCr 3,04900Cr 4.55TCr 32TCr 13TCr 1,59500Cr 12TCr 12TCr 5,06500Cr | EV / Sales 2026 * |
2.65x | EV / Sales 2027 * | 2.48x |
| Free-Float |
67.61% | Yield 2026 * |
1.35% | Yield 2027 * | 1.34% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| DGX | Delayed | |
CBOE
| DGX | Real-time | |
|
London S.E.
| 0KSX | Delayed | |
|
Boerse Muenchen
| QDI | Real-time | |
|
Berne S.E.
| QDI | End-of-day quote | |
|
Mexican S.E.
| DGX * | End-of-day quote | |
|
Deutsche Boerse AG
| QDI | Delayed | |
|
Tradegate
| QDI | Real-time | |
|
Börse Stuttgart
| QDI | Delayed | |
|
Xetra
| QDI | Delayed | |
|
Borsa Italiana
| 1QDX | End-of-day quote |
Last Transcript: Quest Diagnostics Incorporated
| 1 day | +1.26% | ||
| 1 week | +2.80% | ||
| Current month | +5.38% | ||
| 1 month | +3.37% | ||
| 3 months | +4.10% | ||
| 6 months | +25.93% | ||
| Current year | +41.54% |
| 1 week | 239.59 |  | 249.73 |
| 1 month | 223.5 | | 249.73 |
| Current year | 171.18 | | 249.73 |
| 1 year | 171.18 | | 249.73 |
| 3 years | 123.04 | | 249.73 |
| 5 years | 119.59 | | 249.73 |
| 10 years | 73.02 | | 249.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 63 | 03/02/2022 |
Sam Samad
DFI | Director of Finance/CFO | 56 | 11/07/2022 |
Murali Balakumar
CTO | Chief Tech/Sci/R&D Officer | - | 06/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Pfeiffer
BRD | Director/Board Member | 76 | 01/12/2004 |
Timothy Ring
BRD | Director/Board Member | 68 | 07/12/2011 |
James Davis
CHM | Chairman | 63 | 01/04/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Free | Director | 135 | 0.0001% | ||
| 01/09/26 | Sell | Chief Executive Officer | -10,000 | 0.0091% | ||
| 28/08/26 | Exercice | General Counsel | 69,031 | 0.0625% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.26% | +2.80% | +37.77% | +92.37% | 2.67TCr | |
| -1.29% | -3.75% | +9.43% | +35.69% | 12TCr | |
| +2.95% | +0.83% | -0.69% | +105.61% | 9.74TCr | |
| +3.31% | +2.67% | +123.89% | +1,009.30% | 5.92TCr | |
| +0.17% | +1.62% | -6.81% | +89.51% | 2.9TCr | |
| +8.78% | +11.27% | +38.72% | +81.07% | 2.69TCr | |
| +2.46% | -0.23% | +31.22% | +405.46% | 2.11TCr | |
| +0.95% | +3.67% | -17.37% | -0.93% | 2.06TCr | |
| +0.26% | -1.75% | -4.85% | +31.71% | 1.69TCr | |
| -2.97% | -22.92% | -20.92% | +52.10% | 1.42TCr | |
| Average | +1.59% | -0.50% | +19.04% | +190.19% | 4.29TCr | |
| Weighted average by Cap. | +1.50% | -0.12% | +23.66% | +212.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.21TCr 1.08TCr 1TCr 907.81Cr 1.7TCr 1,15100Cr 1.72TCr 12TCr 4.77TCr 60TCr 4.53TCr 4.44TCr 1,91200Cr | 1.26TCr 1.13TCr 1.05TCr 948.2Cr 1.77TCr 1,20200Cr 1.79TCr 13TCr 4.99TCr 63TCr 4.74TCr 4.64TCr 1,99700Cr |
| Net income | 116.38Cr 104.41Cr 97Cr 87Cr 163.34Cr 11TCr 165.32Cr 1.15TCr 459.73Cr 5.8TCr 436.72Cr 427.5Cr 18TCr | 123.7Cr 110.98Cr 102.61Cr 93Cr 173.61Cr 12TCr 175.71Cr 1.23TCr 488.63Cr 6.16TCr 464.18Cr 454.38Cr 20TCr |
| Net Debt | 498.73Cr 447.46Cr 413.69Cr 374.67Cr 699.98Cr 47TCr 708.44Cr 4.95TCr 1.97TCr 25TCr 1.87TCr 1.83TCr 79TCr | 433.69Cr 389.1Cr 359.74Cr 325.81Cr 608.69Cr 41TCr 616.05Cr 4.3TCr 1.71TCr 22TCr 1.63TCr 1.59TCr 69TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $245.62 | +1.26% | 9,32,796 |
| 27/26/27 | $242.56 | -0.16% | 9,19,017 |
| 26/26/26 | $242.95 | +0.44% | 9,59,622 |
| 23/26/23 | $241.89 | -0.57% | 9,33,382 |
| 22/26/22 | $243.28 | +1.82% | 16,86,025 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DGX Stock
Select your edition
All financial news and data tailored to specific country editions
